Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00238485
Status:
COMPLETED
Last Update Posted:
2017-03-28
First Post:
2005-10-12
Brief Title:
An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mgd in the Treatment of Manic Episodes of Bipolar I Disorder
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-12
First Submit QC Date:
October 12 2005
Study First Post Date:
2005-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-24
Last Update Post Date:
2017-03-28
Last Update Post Date Type:
ACTUAL